Mark J. Ratain to Models, Theoretical
This is a "connection" page, showing publications Mark J. Ratain has written about Models, Theoretical.
Connection Strength
0.176
-
Testing the wrong hypothesis in phase II oncology trials: there is a better alternative. Clin Cancer Res. 2007 Feb 01; 13(3):781-2.
Score: 0.057
-
Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysis. Cancer Invest. 2001; 19(1):57-64.
Score: 0.037
-
Genome-wide interrogation of longitudinal FEV1 in children with asthma. Am J Respir Crit Care Med. 2014 Sep 15; 190(6):619-27.
Score: 0.024
-
Phase I study of escalating does of carboplatin. Cancer Chemother Pharmacol. 1994; 34(6):535-6.
Score: 0.023
-
Modeling interpatient pharmacodynamic variability of etoposide. J Natl Cancer Inst. 1991 Nov 06; 83(21):1560-4.
Score: 0.020
-
Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities. Cancer Res. 1986 Sep; 46(9):4874.
Score: 0.014